Fusion Pharm Stock Market Value
| FSPM Stock | USD 0.0001 0.00 0.00% |
| Symbol | Fusion |
Will Consumer Staples Distribution & Retail sector continue expanding? Could Fusion diversify its offerings? Factors like these will boost the valuation of Fusion Pharm. Market participants price Fusion higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fusion Pharm data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.15) | Revenue Per Share 0.133 | Return On Assets (1.38) |
The market value of Fusion Pharm is measured differently than its book value, which is the value of Fusion that is recorded on the company's balance sheet. Investors also form their own opinion of Fusion Pharm's value that differs from its market value or its book value, called intrinsic value, which is Fusion Pharm's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Fusion Pharm's market value can be influenced by many factors that don't directly affect Fusion Pharm's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fusion Pharm's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fusion Pharm is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Fusion Pharm's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Fusion Pharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fusion Pharm's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fusion Pharm.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Fusion Pharm on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Fusion Pharm or generate 0.0% return on investment in Fusion Pharm over 90 days. FusionPharm, Inc. develops, manufactures, and sells a line of cultivation containers under the PharmPod brand name in th... More
Fusion Pharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fusion Pharm's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fusion Pharm upside and downside potential and time the market with a certain degree of confidence.
Fusion Pharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Fusion Pharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fusion Pharm's standard deviation. In reality, there are many statistical measures that can use Fusion Pharm historical prices to predict the future Fusion Pharm's volatility.Fusion Pharm Backtested Returns
We have found three technical indicators for Fusion Pharm, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which means not very significant fluctuations relative to the market. the returns on MARKET and Fusion Pharm are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Fusion Pharm has perfect predictability. Overlapping area represents the amount of predictability between Fusion Pharm time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fusion Pharm price movement. The serial correlation of 1.0 indicates that 100.0% of current Fusion Pharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Fusion Pharm Correlation, Fusion Pharm Volatility and Fusion Pharm Performance module to complement your research on Fusion Pharm. To learn how to invest in Fusion Stock, please use our How to Invest in Fusion Pharm guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Fusion Pharm technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.